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ARF1 Regulates Nef-Induced CD4 Degradation
somes and lysosomes [16–19]. We further demonstratedJulien Faure´,1,5 Romaine Stalder,2,5
Christelle Borel,2,5 Komla Sobo,2 that the Nef-induced lysosomal targeting of CD4 in-
volves Nef-COP interactions [13]. This latter observationVincent Piguet,2,6 Nicolas Demaurex,3
Jean Gruenberg,1,* and Didier Trono2,4,* correlated with the previously reported association of
HIV-1 Nef with COP [20]. However, although our results1Department of Biochemistry
2 Department of Microbiology and Molecular [13] revealed the importance of residues located in a
C-terminal flexible loop of HIV-1 Nef in CD4 late-endoso-Medicine
3 Department of Cell Physiology and Metabolism mal migration, they also indicated that the Nef-COP
interaction strongly depends on a then-unidentified co-4 Frontiers in Genetics Research Program
University of Geneva factor found in a COP-depleted fraction of the cytosol
[13]. Because endosomal COP functions depend on1211 Geneva
Switzerland ARF1 in vitro [21], we reasoned that ARF1 might be the
necessary cofactor. The results presented here indicate
that this is the case.
Summary
ResultsBackground: The HIV Nef protein downregulates CD4
through sequential connection with clathrin-coated pits
Nef Late-Endosomal Targeting and Interactionsand the COP1 coatomer, resulting in accelerated endo-
with ARF1cytosis and lysosomal targeting.
We previously reported that a Nef molecule mutated inResults: Here we report that the small GTPase ARF1
two distal acidic residues (NefEE155QQ) inefficiently tar-controls the Nef-induced, COP-mediated late-endoso-
geted CD4 to lysosomes [13]. To extend this observa-mal targeting of CD4. We find that Nef binds ARF1 di-
tion, we expressed wild-type Nef, NefEE155QQ, or the non-rectly and can recruit the GTPase onto endosomal mem-
myristoylated NefG2A mutant with a Myc-tagged form ofbranes. Furthermore, a complex comprising Nef, ARF1,
ARF1 in BHK cells, prepared early-and late-endosomaland COP can be immunoprecipitated from cells ex-
fractions on a flotation gradient [22], and analyzed thepressing the viral protein. Residues in a C-terminal loop
resulting material by Western blotting (Figure 1). Wild-of the viral protein facilitate both these interactions and
type Nef and NefEE155QQ were both found in early-endo-the targeting of Nef and CD4 to acidic late endosomes,
somal fractions (lanes 3 and 7). However, only the wild-whereas other residues primarily involved in mediating
type protein was detected in late-endosomal fractionsCD4 endocytosis are dispensable for this process. Fi-
(lanes 2 and 6). As expected from its failure to bindnally, a dominant-negative ARF1 mutant blocks the mi-
membranes, NefG2A did not copurify with endosomesgration of the Nef-CD4 complex to lysosomes.
(lanes 10 and 11). ARF1 can interact with several targetConclusions: Our results support a model in which
membranes, including endosomes, and—not surpris-ARF1 is the immediate downstream partner of Nef for
ingly—was found associated with early- and late-endo-CD4 lysosomal targeting.
somal fractions under all conditions. However, ARF1
appeared somewhat more enriched in late endosomesIntroduction
of cells coexpressing wild-type Nef (Figure 1, lane 2),
perhaps suggesting that it played a role in Nef-inducedThe early protein Nef of human (HIV) and simian (SIV)
CD4 late-endosomal targeting. When CD4 was coex-immunodeficiency viruses downregulates CD4, the pri-
pressed with wild-type Nef, its accumulation in late en-mary receptor of these viruses. This event is important
dosomes was not detected by this technique (data notfor preserving the infectivity of released virions [1] and
shown). This contrasts with approaches in which theproceeds through two consecutive steps. At the plasma
receptor is coupled with antibodies at the cell surfacemembrane, Nef connects the cytoplasmic tail of CD4
and then immunofluorescence microscopy is performedwith the adaptor protein complex (AP-2) of clathrin-
(see reference [13] and results below). However, in thiscoated pits and the catalytic subunit of a vacuolar AT-
latter case, the fraction of CD4 molecules that migratesPase, inducing the receptor to be rapidly endocytosed.
from the surface is examined in a dynamic fashion,Then, in early endosomes, Nef interacts with the COP1
within moments of its internalization, and the antibodycoatomer, which targets CD4 to lysosomal degradation
used to tag the receptor likely survives the degradation[2–15].
of CD4 in late endosomes/lysosomes. In contrast, thePrevious studies showed that an endosomal COP
biochemical analysis of purified endosomes providescomplex is involved in transport from early to late endo-
information on the steady-state levels of CD4 molecules
associated with these organelles; these levels are likely
*Correspondence: jean.gruenberg@biochem.unige.ch (J.G.), didier. to be low in late endosomes/lysosomes as a result of
trono@medecine.unige.ch (D.T.)
rapid degradation.5These authors equally contributed to this work.
When Nef carrying the HA epitope was coexpressed6Present address: Clinic of Dermatology and Venereology, University
Hospital, 1211 Geneva, Switzerland. with Myc-tagged ARF1, the two proteins could be coim-
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Figure 1. Nef Associates with Late Endo-
somes in an EE155-Dependent Manner
HA-tagged wild-type Nef or NefEE155QQ, or
NefG2A were coexpressed with ARF1-Myc in
BHK cells. Early- and late-endosomal mem-
branes were separated on a sucrose flotation
gradient and analyzed by Western blotting
with antibodies against HA (wild-type Nef and
NefEE155QQ), Nef (NefG2A), Rab7 (a marker of
late endosomes, LE), and Rab5 (a marker of
early endosomes, EE). PNS: postnuclear su-
pernatant, HM: heavy membranes.
munoprecipitated with antibodies against HA (Figure Because these results suggested that ARF1 and Nef
are part of the same protein complex, we used purified2A). Coimmunoprecipitation was less efficient with a Nef
mutant lacking the diacidic motif (NefEE155QQ) important recombinant versions of the two proteins (His-tagged
ARF1 and GST-Nef) to determine whether they canfor Nef-induced CD4 late-endosomal targeting [13].
interact directly. After coincubation, ARF1 could be cap-
tured onto glutathione beads via GST-Nef (Figure 2B).
ARF1 also copurified with GST fused with the NefLL165AA
mutant, which is deficient in AP2-dependent inter-
nalization [23]. In contrast, ARF1 did not associate to
any significant extent with the purified GST-NefEE
155QQ mutant.
Nef-Mediated Recruitment of ARF1
on Endosomes
Nef is tethered to the membrane by N-terminal myristoy-
lation and might be able to recruit ARF1 onto endo-
somes. However, when bound to GTP, ARF1 can also
interact with the bilayer by exposing an N-terminal myri-
stoyl head followed by a stretch of charged residues
presumably involved in phospholipid binding (a struc-
tural modification known as a myristoyl switch) [24, 25].
We therefore used an ARF1 mutant (ARF117) that can-
not associate spontaneously with the lipid bilayer as a
result of a 17 residue N-terminal deletion that eliminates
the myristoylation site and the stretch of charged amino
acids. After coexpression of CD4 and wild-type Nef or
NefEE155QQ, endosomal membranes were prepared by
flotation gradient [26] and incubated with recombinant
ARF117 in vitro (Figure 3A). ARF117 was selectively
recruited onto endosomes of cells expressing wild-type
Nef. A small degree of ARF117 recruitment was ob-
served in control cells, suggesting that this molecule
may also bind endogenous endosomal proteins. Of note,
the same background level of binding was detected with
endosomes of cells expressing NefEE155QQ.
Figure 2. Nef Interacts with ARF1 in an EE155-Dependent Manner Because ARF1 can be recruited by membrane-associ-
(A) Lentiviral vectors expressing HA-tagged wild-type Nef or ated Nef and is involved in early- to late-endosomal
NefEE155QQ, CD4 and Myc-tagged ARF1 were introduced into BHK transport, we investigated whether Nef was able to bind
cells. Top: after immunoprecipitation with antibodies against HA, to the different forms of the GTPase. We first made
samples were analyzed by SDS-PAGE and Western blotting with
use of the well-characterized T31N dominant-negativeantibodies against HA and Myc. Bottom: the Nef and ARF1 contents
ARF1mutation, which prevents GTP loading. After coex-of the samples were analyzed by SDS-PAGE and Western blotting.
Numbers represent the results of quantification, the signal obtained pression in vivo, ARF1T31N, much like wild-type ARF1,
for each protein in the wild-type Nef-containing sample being given could be coimmunoprecipitated with wild-type Nef but
the arbitrary value of 1. not with NefEE155QQ (Figure 3B). Similarly, recombinant
(B) E. coli-produced His-tagged ARF1 and the indicated GST-Nef ARF1T31N interacted in vitro with GST-Nef but not withproteins were coincubated in vitro before capture onto gluthatione
GST-NefEE155QQ (Figure 3C). Because the T31N mutationbeads and analysis by SDS-PAGE and Western blotting with anti-
inhibits GTP binding, and thus also the GTP-dependentHis6 antibodies (top). Amounts of GST-Nef present on the blotting
membrane were determined by Ponceau red staining (bottom). myristoyl switch of ARF1, our observations that Nef in-
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teracts with both ARF1T31N and ARF117 are consistent.
Nef could also be coimmunoprecipitated with ARF1Q71L,
an ARF1 mutant stabilized in the GTP bound, active
form (not illustrated), indicating that the association be-
tween the viral protein and ARF1 is not affected by the
nature of the nucleotide bound to the GTPase.
Nef-ARF1-COP Trimolecular Complex
Because Nef can recruit ARF1 to endosomal mem-
branes and because previous studies demonstrated that
(1) ARF1 recruits the  subunit of the COP1 complex
[17, 27], (2) COP is involved in endosomal transport
[16–19], and (3) Nef can associate with COP [13, 20],
we asked whether Nef can form a ternary complex with
endogenous ARF1 and COP. For this, extracts of 293T
cells expressing a Myc-tagged form of COP (COP-
Myc) with or without HA-tagged forms of wild-type or
EE155QQ HIV-1 Nef (Nef-HA and NefEE155QQ-HA, respec-
tively) were subjected to immunoprecipitation with a
Myc-specific antibody (Figure 4A). Detectable amounts
of endogenous ARF1 could be immunoprecipitated with
COP-Myc only in the presence of Nef, and the EE155QQ
mutation decreased the amount of Nef and ARF1 associ-
ated with COP by about 35% in this type of assay. As
well, Nef-HA and endogenous COP could be immuno-
precipitated with antibodies against the Myc epitope
of ARF1-Myc in an EE155-enhanced fashion (Figure 4B).
These results lend support to the existence of a trimo-
lecular complex containing Nef, ARF1, and COP, the
formation of which is influenced by the Nef acidic dipep-
tide. The persistence of a significant degree of Nef-
ARF1-COP coimmunoprecipitation with NefEE155QQ
suggests that independent interactions take place be-
tween Nef and the other two proteins and that some of
these interactions, namely between Nef and COP, are
not influenced by this particular sequence motif.
ARF1 and Nef-Induced Transport of CD4 to Acidic
Late-Endosomal Compartments
We investigated further the possible role of ARF1 in Nef-
induced CD4 trafficking to acidic late-endocytic com-
partments. We first measured the rates of CD4 endocy-
tosis. In the absence of Nef, CD4 internalization was
only marginally, if at all, affected by overexpression of
either wild-type ARF1 or ARF1T31N. As expected, NefFigure 3. Nef Recruits ARF1 on Endosomal Membranes
overexpression greatly stimulated CD4 endocytosis,(A) HA-tagged wild-type Nef or NefEE155QQ and CD4 were coex-
pressed in BHK cells. Endosomal membranes were prepared and and this increased uptake was largely preserved when
incubated in vitro with recombinant, purified His-tagged ARF117. either form of the GTPase was expressed (not illus-
Then, membranes were retrieved by flotation in a sucrose gradient trated). We then examined CD4 late-endosomal trans-
and analyzed as above, with antibodies against HA (Nef) or His6 port (Figure 5A). To identify late endosomes unambigu-(ARF117).
ously, we used lyso-bisphosphatidic acid (LBPA) as a(B) HA-tagged wild-type Nef or NefEE155QQ CD4 and Myc-tagged
marker [28]. When expressed alone, CD4 was only mar-ARF1T31N were coexpressed in 293T cells. After crosslinking and
immunoprecipitation with antibodies against Nef, samples were an- ginally detected within late endosomes containing LBPA
alyzed with antibodies against HA and Myc. Numbers under bands (10% of the internalized CD4 molecules colocalized
represent the results of quantification, values obtained for each with LBPA). In contrast, in the presence of Nef, endocy-
protein in the wild-type Nef sample being assigned the arbitrary
tosed CD4 molecules were efficiently transported to thisvalue of 1.
compartment (44% colocalization). The Nef-induced(C) Recombinant His-tagged ARF1T31N and wild-type or mutant
late-endosomal transport of CD4 was much less efficientGST-Nef proteins were produced in E. coli, purified, mixed, and
analyzed with antibodies against His. in cells expressing NefEE155QQ (19% colocalization).
When wild-type ARF1 was overexpressed, some CD4
appeared to be sequestered in regions adjacent to the
plasma membrane, often in clusters of vesicles, presum-
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tosis of CD4 was slow in the presence of the AP binding-
defective NefLL165AA mutant, internalized receptor mole-
cules were targeted to late endosomes (Figure 5B, top),
correlating this mutant’s ability to bind ARF1. A Nef
mutant altered in the downstream acidic motif DD174,
previously demonstrated to be crucial for binding the
catalytic subunit of a vacuolar ATPase and for accelerat-
ing CD4 endocytosis [15], induced a similar phenotype
(Figure 5B, bottom). With both of these mutants, even
though a large fraction of CD4 molecules were retained
at the plasma membrane, those internalized clustered
in the paranuclear area, where they strongly colocalized
with LBPA. This contrasted with the “starry sky” pattern
of CD4 distribution induced by NefEE155QQ; in that pat-
tern, the majority of receptor molecules associated with
early/recycling endosomes [13]. These findings indicate
that the binding of Nef to the adaptor protein complex,
a process in which the LL165 motif plays a crucial role,
and to the vacuolar ATPase, another proposed mediator
of Nef-induced CD4 endocytosis, is not essential for
CD4 late-endosomal targeting.
To monitor the pH of vesicles containing internalized
CD4, we labeled the receptor with FITC-coupled anti-
CD4 antibody at the cell surface and allowed endocyto-
sis to proceed at 37C for 60 min. The pH of endosomes
containing the internalized antibody was then quantified
by fluorescence microscopy [13, 29] (Figure 5C). In the
absence of Nef, CD4 was mostly found in vesicles with
a mildly acidic pH (pH  6.3), corresponding to that of
early endosomes (not shown). In contrast, expression
of wild-type Nef caused CD4 to distribute within vesicles
with a low pH, consistent with that of late endosomes
and lysosomes. Transport of CD4 to acidic compart-
ments was inhibited when the diacidic motif required
for ARF1 binding was inactivated in the NefEE155QQ mu-
tant, as previously observed [13]. Overexpression of
wild-type ARF1 did not prevent CD4 transport to acidic
compartments. However, consistent with our light mi-
croscopy analysis (Figure 5A), the retention of some
CD4 at or near the plasma membrane of cells overex-Figure 4. COP-ARF1-Nef Interactions
pressing the GTPase accounted for a significant fraction(A) HA-tagged Nef (wild-type or EE155QQ), CD4, and Myc-tagged
of CD4-containing structures with a pH between 7 andCOP were coexpressed in 293T cells. Samples of extracts were
analyzed by SDS-Page and Western blotting with antibodies against 7.5. In cells producing the dominant-negative ARF1 mu-
HA, Myc and ARF without (top) or with (bottom) prior immunoprecipi- tant T31N, wild-type Nef was no longer able to target
tation with Myc-specific antibodies. CD4 to acidic vesicles. Of note, the acidification capacity
(B) Same type of experiment, but with extracts of cells expressing of late-endocytic compartments was not compromised,Nef-HA and ARF1-Myc being immunoprecipitated with Myc-specific
as assessed with Lysotracker red (not shown). Together,antibodies and with antibodies against HA, Myc, and endogenous
these experiments support a model in which ARF1 isCOP (top and bottom) and ARF (top) being used for the Western
blot. involved in the Nef-induced transport of CD4 to acidic
Numbers represent the results of quantification, the signals obtained late endosomes and lysosomes.
in the sample containing wild-type Nef being given the arbitrary
value of 1 for each protein. In (B), the COP Western blot performed
on the anti-Myc immunoprecipitates detects a background band Colocalization of Nef, ARF1, and COP(top), also quantified as an internal control.
in Early Endosomes
We then examined the possible colocalization of Nef,
ARF1, and endosomes. For this, we made use of theably reflecting the increased activity of the GTPase
(arrows). However, CD4 still migrated to LBPA-con- chimeric protein 44Nef, which comprises the extra-
cellular and transmembrane domains of CD4 fused withtaining vesicles (20% colocalization). In contrast, this
process was strongly inhibited upon expression of Nef. HeLa cells were transfected with both 44Nef or
44NefEE155QQ and ARF1-gfp or ARF1T31N-gfp. Cell sur-ARF1T31N, with the receptor remaining essentially within
LBPA-negative peripheral endosomes (10% colocaliza- face CD4 determinants were labeled with a specific anti-
body, and endocytosis was allowed to proceed for 40tion). CD4 migration was also inhibited after expression
of ARF1Q71L (data not shown). Of note, although endocy- min. Cells were then fixed and incubated with antibodies
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Figure 5. Transport to LBPA-Containing Acidic Late Endosomes
(A) CD4 molecules at the surface of transfected Hela cells were labeled with T4-4 monoclonal antibody and allowed to internalize at 37C for
60 min. The distribution of antibody-tagged CD4 molecules was then analyzed by confocal microscopy, and cells were further labeled with
antibodies against the late-endosomal lipid lysobisphosphatidic acid followed by Alexa 568- (for LBPA) and 488- (for CD4) conjugated secondary
antibodies. For each transfection, one representative confocal plane, representative of more than 100 cells examined, is shown. Percentages
ARF1 Regulates Nef-Induced CD4 Degradation
1061
against the early-endosomal marker EEA1 before exami- more, our data indicate that, although the EE155QQ muta-
tion severely affects Nef-induced CD4 lysosomal tar-nation by indirect immunofluorescence and confocal
geting, it only partially abolishes the association of Nefmicroscopy (Figure 6). Wild-type 44Nef, but not the
with COP. This suggests that several interactions may44NefEE155QQ mutant, showed a significant degree of
take place within the Nef-ARF1-COP complex, not all ofcolocalization with ARF1-gfp and EEA1 (Figures 6A and
which are affected by the Nef acidic dipeptide mutation.6B). In the absence of Nef, ARF1T31Ngfp was fully cyto-
The C-terminal loop of Nef is involved in recruitingsolic and leaked from the methanol-fixed cells (not illus-
the proposed cellular mediators both of CD4 endocyto-trated). As expected from the results of our biochemical
sis, i.e., the adaptor complex and the vacuolar ATPase,analyses, 44Nef weakly stabilized the mutant form of
and of CD4 late-endosomal targeting, i.e the COP1 co-the GTPase onto endosomes (Figure 6C). In contrast,
atomer. The bindings of these two sets of mediatorsno such effect was observed with 44NefEE155QQ because,
are most likely mutually exclusive because of spacein this case, most of the mutant ARF1 molecules leaked
constraints. This fits well with the sequential involve-out of the fixed cells (Figure 6D). As well, colocalization
ment of these cellular complexes in Nef-mediated CD4of Nef, ARF1-gfp, and COP was dependent on the
downregulation; adaptins and the vacuolar ATPase arepreservation of the Nef EE155 sequence (Figures 6E and
recruited at the plasma membrane for CD4 internaliza-6F). Finally, in the presence of brefeldin A, a drug that
tion via clathrin-coated pits, and the COP1 coatomer isprevents the formation of ARF-GTP, CD4 late-endoso-
recruited in early endosomes for CD4 lysosomal tar-mal targeting was inhibited, and the colocalization of
geting. However, there is not a complete overlap in the44Nef, ARF1gfp, and early-endosomal markers was lost
residues involved in binding either complex or in the(not illustrated). Together, these results strongly support
functional consequences of their mutation. For instance,a model in which ARF1 is involved in the Nef-induced
mutating EE155 in Nef does not alter Nef binding totransport of CD4 to an acidic late compartment.
adaptins or the acceleration of CD4 endocytosis but
interferes with CD4 lysosomal targeting [13]. Recipro-
Discussion
cally, the LL165 and DD174 mutants can target CD4 to late
endosomes, but without initially inducing CD4 internal-
Four lines of evidence point to ARF1 as the immediate ization.
downstream partner of Nef for the lysosomal targeting Our attempts to generate a multimolecular complex
of CD4. First, Nef binds ARF1 directly and is capable comprising Nef, ARF1, and COP by using recombinant
of recruiting the GTPase onto endosomal membranes. ARF1 synthesized in E. coli have been unsuccessful,
Second, these interactions are influenced by residues perhaps because of posttranslational ARF1 modifica-
in a C-terminal flexible loop of Nef; these residues are tions not recapitulated in vitro. Alternatively, such a
also important for Nef association with late endosomes complex may require other factors or may be very tran-
and targeting of CD4 molecules to this compartment. sient. Similarly, in the biosynthetic pathway, ARF1 is
Third, a complex comprising Nef, ARF1, and COP can known to bind coatomer in close proximity to the cargo
be detected in cells expressing the viral protein. Fourth, binding site [31], but the nature of possible complexes
expression of a dominant-negative ARF1 mutant or of cargo molecules, ARF1, and coatomer is not clear.
treatment with brefeldin A blocks the lysosomal tar- Some biosynthetic cargo molecules were proposed to
geting of CD4. These data complement our previous modulate ARF1 GTPase activity [32], but whether this
demonstration of an EE155-promoted, yet largely indirect modulation depends on coatomer remains an unsolved
interaction between Nef and COP and of the COP1- issue [33–35].
dependent, Nef-induced lysosomal transport of CD4 It is tempting to postulate that Nef, like the ARF1
[13]. Altogether, our results support a model in which exchange factor ARNO [36], stabilizes ARF1 at the mem-
ARF1 connects the CD4-Nef complex with this coat brane independently of the nucleotide state of the
structure and thereby plays a crucial role in the late- GTPase. Although we were unable to reveal GDP-GTP
endosomal targeting of CD4 by the viral protein. exchange activity for Nef toward ARF1 in vitro, we can-
The Nef EE155 sequence was found not to influence not rule out the possibility that the viral protein exerts
the binding of Nef to COP in the yeast two-hybrid this action in vivo, for instance if it requires that Nef be
system or of GST-Nef to an in vitro-translated C-terminal bound to CD4. Alternatively, Nef may prime ARF1 for
fragment of COP [30]. However, Nef-mediated recruit- subsequent GTP exchange. The dominant interference
ment of COP1 constituents is most likely indirect and imposed by ARF1T31N suggests that, although dispens-
depends on a critical cofactor [13]. The present work able for Nef binding, ARF1 activation is required for CD4-
Nef transport to acidic late endosomes. These observa-strongly suggests that ARF1 is this cofactor. Further-
represent the proportion of CD4-specific green signal overlapping with the 6C4-specific red signal. In cells overexpressing ARF1, some CD4
is sequestered in the juxtamembrane region (arrows). However, CD4-LBPA colocalization is far more pronounced than in the presence of
ARF1T31N.
(B) The same experiment with the endocytosis-defective NefLL165AA NefDD174AA mutants. In these cases, a large fraction of CD4 molecules
stay at the plasma membrane, but those internalized are predominantly found colocalizing with LBPA in the perinuclear region.
(C) CD4  Nef or NefEE155QQ, CD4  Nef  ARF1, or CD4  Nef  ARF1T31N were coexpressed in HeLa cells, and cell-surface CD4 molecules
were labeled with anti-CD4 antibody conjugated to FITC. After reincubation at 37C for 60 min, FITC fluorescence was used for measuring
the pH of vesicles containing the internalized antibody, as previously described [13]. Mean pH is indicated in each case, with the number in
parentheses indicating the number of vesicles included in each analysis.
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Figure 6. Colocalization of Nef and ARF1 on Early Endosomes
44Nef (A, C, and E) or 44NefEE155QQ (B, D, and F) was coexpressed with ARF1gfp (A, B, E, and F) or ARF1T31Ngfp (C and D) in HeLa cells. CD4
molecules at the surface of the cells were labeled with T4-4 monoclonal antibody and allowed to internalize at 37C for 40 min. Cells were
further labeled with antibodies against the early-endosomal marker EEA1 (A–D) or COP (E and F) and examined by confocal microscopy.
EH1 clones, all obtained from the AIDS Research and Referencetions fit well with our previous findings that ARF1 is
Reagent Program, Division of AIDS, NIH), anti-Nef polyclonal [37],involved in the in vitro formation of multivesicular trans-
anti-LBPA (6C4) [28], anti-COP (Sigma, clone maD), anti-EEA1port intermediates destined for late endosomes [21].
(Transduction Lab), and anti-ARF (which recognizes ARF1, 3, 5, and
Because ARF1 recruits endosomal COPs [21], which 6) (1D9, Alexis).
are required at the same transport step [16–19], and
because these are also involved in Nef:CD4 downregula- Plasmids
tion [13], an attractive model is that Nef acts by nucleat- The ARF1 cDNA (gift from V. Faundez, UCSF, San Fransisco) was
amplified by PCR to encode an ARF1-Myc fusion protein and wasing the transport machinery via ARF1 binding. By hi-
inserted into a pCB6 vector [38]. ARF1T31N-Myc and ARF1Q71L-Mycjacking ARF1, Nef may have evolved an efficient way to
were generated with the Quickchange Stratagene kit. For obtainingovercome endosomal controls in order to divert CD4
ARF1-GFP fusion expression vectors, the appropriate cDNA was
into the pathway leading to its degradation in late endo- subcloned into pEGFP-N (Clontech). For generating an ARF1-His6
somes and lysosomes. fusion protein, ARF1 cDNA was introduced into pET20b (Novagen)
vector. ARF117-His6 was obtained by mutagenesis of the first ATG
codon into a TTG codon. The wild-type Nef encoding sequenceExperimental Procedures
was derived from the HIV1 R7 recombinant clone [39], with two
differences relative to the published sequence (E151D and E158K).Cell Culture and Immunological Reagents
Baby hamster kidney cells (BHK-21), Hela cells, and 293T cells (pro- CMV-based expression plasmids producing CD4, both wild-type
and mutant forms of Nef, and CD4-Nef chimeras were describedvided by G. Nolan, Stanford University) were grown and maintained
in DMEM medium with 10% FCS, 100g/ml of penicillin and strepto- [2, 13]. In some vectors, three copies of the influenza hemagglutinin
epitope were added to Nef C terminus by oligo-directed mutagene-mycin, and 2 mM glutamine. The following antibodies were used:
anti-His6 C-ter (Invitrogen), anti-HA (3F10, Roche; HA.11, Covance), sis. BHK cells stably expressing Nef and CD4 were obtained by
lentiviral vector-mediated transduction with a second-generationanti-Myc-tag (9E10, Roche), anti-CD4 PE or FITC-conjugated
(MT310, Dako), anti-CD4 (T4-4), anti-Nef (AE6, HIV1 JR-CSF, and packaging system [40]. For generating the pHRCMV-CD4 vector,
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